We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more about our cookie and privacy policy.
HPLC vs. Mass Spectrometry
Last reviewed: August 2, 2026
These two techniques appear side by side on peptide paperwork so routinely that they are often read as one combined quality score. They are not. HPLC and mass spectrometry measure different physical properties and answer different questions, and understanding which question each one settles is the difference between reading a certificate and skimming it.
Two Different Questions
Put as plainly as possible:
- HPLC asks: how much of this sample is a single substance? It separates a mixture into components and reports their relative proportions. It is a purity measurement.
- Mass spectrometry asks: what is that substance? It measures mass-to-charge ratio, which for a peptide is a direct consequence of its atomic composition. It is an identity measurement.
Neither answers the other's question. A sample can be 99.8% one compound that is not the compound you ordered, and HPLC alone will report a beautiful chromatogram. Conversely, mass spectrometry can confirm the intended molecule is present without saying whether it accounts for 99% of the vial or 40%.
What HPLC Actually Does
High-performance liquid chromatography pushes a dissolved sample through a packed column under pressure. For peptides the standard configuration is reversed-phase: a non-polar stationary phase (typically C18 alkyl chains bonded to silica) and a polar mobile phase, usually a water/acetonitrile gradient with about 0.1% trifluoroacetic acid as an ion-pairing modifier.
Separation happens because different molecules partition differently between the two phases. A more hydrophobic molecule spends more time associated with the C18 surface, moves down the column more slowly, and emerges later. The time from sample introduction to detection is the retention time, and under fixed conditions it is reproducible — which is what makes it useful for comparing runs.
A detector at the column outlet, almost always UV at 214 nm or 220 nm, records absorbance over time. That trace is the chromatogram. Integrating the area under each peak and expressing the main peak as a percentage of the total integrated area gives the area-percent purity figure that appears on certificates.
What HPLC Can Miss
Three blind spots are worth naming, because each one is routinely exploited or simply overlooked:
- Co-elution. Two different molecules with similar hydrophobicity can emerge together and integrate as one peak. Deletion sequences — chains missing a single residue from an incomplete coupling step — are the classic case, because removing one amino acid from a twenty-residue chain often barely shifts its retention behaviour.
- Anything that does not absorb UV at the detection wavelength. Counter-ions, inorganic salts and water are essentially invisible at 214 nm. They contribute mass to the vial and nothing to the chromatogram.
- Method dependence. Gradient slope, run length, column chemistry and temperature all change what resolves. A steeper gradient over a shorter run will generally report a higher number on identical material. This is why a purity figure without a method attached is not a result.
What Mass Spectrometry Actually Does
A mass spectrometer converts molecules into gas-phase ions, separates those ions by their mass-to-charge ratio (m/z), and counts them. For peptides the near-universal ionisation method is electrospray ionisation (ESI), which is gentle enough to bring an intact peptide into the gas phase without fragmenting it. MALDI is the other common choice.
ESI has a characteristic that surprises people reading their first peptide spectrum: it produces
multiply charged ions. A peptide picks up several protons, so a single compound
appears as a family of peaks rather than one. A peptide of average mass 3,357.9 Da shows
[M+2H]2+ at roughly m/z 1,679.9 and
[M+3H]3+ at roughly m/z 1,120.3 — the general relation being
m/z = (M + n×1.008) / n. Software deconvolutes that series back to a
single neutral mass, and it is the deconvoluted value that should be compared against the mass
calculated from the sequence.
The comparison is exacting. Molecular mass is fully determined by atomic composition, so the theoretical value is not an estimate — it is arithmetic. An observed mass that does not match means the molecule is not the molecule.
Reading Mass Discrepancies
Common differences and what they usually indicate:
- −18 Da: loss of water. Often an aspartimide or a succinimide intermediate formed at an Asp or Asn residue.
- −17 Da: loss of ammonia, or a free acid where a C-terminal amide was specified.
- +16 Da: oxidation, most often at methionine, cysteine or tryptophan.
- +42 Da: acetylation — expected if the sequence is specified as N-terminally acetylated, a contaminant if it is not.
- A residue-sized gap: a deletion sequence. Glycine is 57 Da, alanine 71, and so on up to tryptophan at 186.
What Mass Spectrometry Can Miss
Mass measures composition, not arrangement. Two peptides with identical amino acid composition in a different order are isobaric — the same mass, indistinguishable to a simple mass measurement. Leucine and isoleucine are structural isomers and identical in mass. D- and L-amino acids are identical in mass. Resolving these requires tandem mass spectrometry, which fragments the chain and reads the sequence from the fragment ladder, or an orthogonal technique.
Why the Two Are Run Together
Their blind spots are complementary, and that is the whole point.
The single most common analytical failure in peptide synthesis is a deletion sequence that co-elutes with the target. HPLC integrates it into the main peak and reports high purity. Mass spectrometry sees a second species at a mass short by exactly one residue and flags it immediately. Run in the other direction, mass spectrometry confirms the target molecule is present while saying nothing about the 3% of the sample that is a truncated by-product; HPLC quantifies it.
LC-MS couples the two directly — the chromatographic effluent feeds straight into the mass spectrometer, so every peak in the trace gets a mass assigned to it. That is the strongest routine configuration, because it converts "there is a small peak at 8.4 minutes" into "there is a small peak at 8.4 minutes whose mass is 18 Da below target."
A Worked Example
Applying the distinction to a real supply chain: Quill Peptides material is characterised on both axes — ≥99% purity determined by reversed-phase HPLC, with identity confirmed by mass spectrometry against the theoretical mass for the sequence, performed at an independent third-party laboratory and reported per batch.
The reason to state it that way rather than as "lab tested" is the substance of this whole article. Two techniques, two questions, two results. When you evaluate any supplier — including this one — the useful test is whether both questions have been answered on the specific lot you are being sold, or whether one number has been asked to do the work of two.
Quick Reference
- Property measured: HPLC — partitioning between a stationary and mobile phase. MS — mass-to-charge ratio of gas-phase ions.
- Question answered: HPLC — how much? MS — what?
- Output: HPLC — a chromatogram and an area-percent. MS — a spectrum and an observed mass.
- Principal blind spot: HPLC — co-eluting impurities and UV-transparent mass. MS — isomers and sequence order.
- On a certificate: both, on the same lot, with methods stated.
This article is provided for laboratory and research education only. It does not describe, recommend, or endorse the administration of any compound to a human or animal, and nothing on this page is medical, veterinary, or dosing advice. Quill Peptides products are sold strictly for in-vitro laboratory research use by qualified researchers.